The pharmaceutical industry is built on a simple but expensive reality: most experiments fail, but the few that succeed reshape […]
We recently came across an insightful interview with Vikram Shukla, and it was far more than just a discussion about
On a rainy morning in a Boston biotech boardroom, a licensing discussion unfolds that reflects one of the most expensive
Patient engagement platforms have become central to clinical trials as pharma shifts toward decentralized, hybrid, and AI-enabled study models. In
The consumer DNA testing market in 2025 continued to evolve from a simple ancestry trend into a global business connected
Across hospitals in Germany, diabetes clinics in Saudi Arabia, laboratories in the UK, and healthcare centers in South Africa, safety
Every morning across Europe, the Middle East, and Africa, millions of people begin their day with a finger prick or
The U.S. telehealth market in 2024 is valued at approximately $35–45 billion in direct telemedicine services, while the broader virtual
The U.S. contract research, development, and manufacturing organization (CRDMO) industry has become one of the most important pillars of the
The global consumer health industry has become one of the most powerful sectors within healthcare, supported by increasing awareness about